Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Medicinal Chemistry"
DOI: 10.1021/acs.jmedchem.2c00154
Abstract: Macrocyclic peptides can disrupt previously intractable protein–protein interactions (PPIs) relevant to oncology targets such as KRAS. Early hits often lack cellular activity and require meticulous improvement of affinity, permeability, and metabolic stability to become viable…
read more here.
Keywords:
identification system;
macrocyclic peptides;
ligand identification;
identification ... See more keywords